A skull fracture is a serious injury that is caused by a direct impact to the bone of the skull. The bone can fracture in several ways, including linear, comminuted, or depressed fractures, often with associated soft tissue injuries due to the blunt force trauma. Skull fractures can be considered a form of traumatic brain injury, and it is important to recognize the serious potential for further complications. After sustaining a head injury, a physician should assess the patient for a skull fracture, which can be diagnosed with X-rays, CT scans, and sometimes an MRI. Linear fractures tend to be a crack in the skull bone without much displacement. In comminuted fractures, there is a significant displacement of fragments in multiple directions. Depressed fractures involve the laceration of underlying brain tissue. In most cases, skull fractures will require immediate medical attention due to the risk of an intracranial haematoma (collection of blood inside the skull). Emergent surgery may be required to relieve pressure and reduce the risk of further neurological damage. Surgery may also be conducted to realign the fragments of the fractured skull or to secure them in place with a plate. In some cases, surgery may not be necessary and the patient can be managed with the help of anti-inflammatory medication and rest. Further treatment options, such as physical therapy, may also be prescribed to help restore head movement and reduce the risk of further injury. Overall, skull fractures can be very serious, and it is important to seek medical attention immediately after sustaining a head injury. Appropriate diagnosis and treatment can aid in recovery and reduce the risk of further complications.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom